Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001390574 | SCV001592334 | pathogenic | Carney-Stratakis syndrome; Pheochromocytoma; Paragangliomas 1; Cowden syndrome 3 | 2020-10-18 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 1-2 of the SDHD gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 2 of the SDHD gene. This is expected to result in an absent or disrupted protein product. This variant has been observed in individual(s) with head and neck paragangliomas (HNPGL) (PMID: 19351833, Invitae). Loss-of-function variants in SDHD are known to be pathogenic (PMID: 19454582, 19802898). For these reasons, this variant has been classified as Pathogenic. |